SSAT State-of-the-Art Conference

Journal of Gastrointestinal Surgery

, Volume 16, Issue 9, pp 1641-1644

First online:

Overview of Personalized Medicine in GI Cancers

  • Celia ChaoAffiliated withDivision of Surgical Oncology, Department of Surgery, Sealy Center for Cancer Cell Biology, University of Texas Medical Branch Email author 

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Cancer biomarkers may be used for prevention (identification of patients at high risk for cancer), estimating prognosis and/or repsonse to conventional chemotherapies, or guide the use of specific targeted therapies. This overview provides examples in each category for gastrointestinal cancers and reviews current concepts in personalized medicine.


Targeted therapy Personalized medicine